TickerFactsScreenerDevelopers

Sigyn Therapeutics, Inc. (SIGY) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2014: $952015: $638.8K2016: $149.6K2017: $9.6K2018: $7.5K2019: $5002020: $84.4K2021: $341.0K2022: $8.4K2023: $11.7K2024: $12.1K$12.1K
2014Cash & Equivalents (USD)2024
Fiscal YearCash & EquivalentsChange YoY
2024$12.1K+3.9%
2023$11.7K+39.9%
2022$8.4K-97.5%
2021$341.0K+304.0%
2020$84.4K+16780.4%
2019$500-93.3%
2018$7.5K-21.8%
2017$9.6K-93.6%
2016$149.6K-76.6%
2015$638.8K+672346.3%
2014$95—